Growth hormone secretagogue

0 marketed 2 in Phase 3

This page covers all Growth hormone secretagogue drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Ghrelin receptor (GHSR-1a), Ghrelin receptor (GHS-R1a).

Targets

Ghrelin receptor (GHSR-1a) · Ghrelin receptor (GHS-R1a)

Phase 3 pipeline (2)

MHOS/SHP615 · Shire · Endocrinology
MHOS/SHP615 is a long-acting growth hormone secretagogue (ghrelin receptor agonist) that stimulates growth hormone release.
KW-6500 · Kyowa Kirin Co., Ltd. · Endocrinology
KW-6500 is a long-acting growth hormone secretagogue that stimulates growth hormone release by activating ghrelin receptors.